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Abstract
 
The integral membrane adapter protein linker for activation of T cells (LAT) performs a criti-
cal function in T cell antigen receptor (TCR) signal transduction by coupling the TCR to
downstream signaling pathways. After TCR engagement, LAT is tyrosine phosphorylated by
ZAP-70 creating docking sites for multiple src homology 2–containing effector proteins. In
 
the Jurkat T cell line, the distal four tyrosines of LAT bind PLC
 
 
 
-1, Grb2, and Gads. Muta-
tion of these four tyrosine residues to phenylalanine (4YF) blocked TCR-mediated calcium
mobilization, Erk activation, and nuclear factor (NF)-AT activation. In this study, we exam-
ined whether these four tyrosine residues were essential for T cell development by generating
LAT “knock-in” mutant mice that express the 4YF mutant protein under the control of en-
dogenous LAT regulatory sequences. Significantly, the phenotype of 4YF knock-in mice was
 
identical to LAT
 
 
 
/
 
 
 
 (null) mice; thymocyte development was arrested at the immature
CD4
 
 
 
CD8
 
 
 
 
 
stage and no mature T cells were present. Knock-in mice expressing wild-type
LAT protein, generated by a similar strategy, displayed a normal T cell developmental profile.
These results demonstrate that the distal four tyrosine residues of LAT are essential for
preTCR signaling and T cell development in vivo.
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Introduction
 
Engagement of the TCR initiates a signaling cascade that
results in proliferation, cytokine production, and effector
responses. After TCR cross-linking, the invariant chains of
the TCR are rapidly tyrosine phosphorylated creating
docking sites for the recruitment and activation of src ho-
mology 2 (SH2) domain–containing protein tyrosine ki-
nases (PTKs) such as ZAP-70. These PTKs activate other
downstream effector molecules thereby triggering signaling
pathways that lead to calcium mobilization and mitogen-
activated protein (MAP) kinase activation (1, 2).
The adapter protein linker for activation of T cells
 
(LAT)
 
*
 
 is one of the predominant tyrosine phosphorylated
proteins observed after T cell activation (3). LAT contains
two juxtamembrane cysteine residues that serve as palmi-
toylation sites, targeting the protein to glycolipid-enriched
microdomains in the cell membrane (4). After TCR en-
gagement, LAT is tyrosine phosphorylated by ZAP-70,
creating docking sites for multiple downstream SH2-con-
taining effector proteins. Proteins that associate directly or
 
indirectly with LAT include: PLC-
 
 
 
1, the p85 subunit of
PI3-kinase, Grb2, Grap, SLP-76, Vav, Itk, Cbl, and Gads
(3, 5–7). T cell lines deficient in LAT undergo proximal
activation steps such as TCR-
 
 
 
 chain phosphorylation and
recruitment and phosphorylation of ZAP-70, but exhibit
markedly decreased tyrosine phosphorylation of PLC-
 
 
 
1,
calcium mobilization, Ras and Erk activation, and tran-
scriptional activation of AP-1 and nuclear factor (NF)-AT
after TCR cross-linking, suggesting that in the absence of
LAT, the TCR is uncoupled from downstream signaling
pathways (8, 9). Transfection of wild-type human LAT
cDNA into these cell lines reconstituted normal activation
responses to TCR stimulation. Recently, these LAT-defi-
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cient cell lines were also used as recipients for transfection
with mutant LAT cDNAs to examine the importance of
various LAT tyrosine residues (5). The results of this study
demonstrated distinct and overlapping functions of the dis-
tal four tyrosines. The LAT mutant lacking all four distal
tyrosines failed to bind Grb2, Gads, and PLC-
 
 
 
1, and
LAT-deficient cells reconstituted with this mutant failed to
respond to TCR cross-linking (5).
The generation of LAT-deficient mice has also revealed
a critical role for this protein during T cell development.
LAT
 
 
 
/
 
 
 
 mice contain no mature T cells, including lym-
phoid 
 
  
 
 T cells, 
 
  
 
 T cells, and intestinal intraepithelial
lymphocytes (10). Moreover, thymocyte development is
blocked at the immature CD4
 
 
 
CD8
 
 
 
 stage, suggesting that
LAT is required for preTCR signaling. T cell development
requires the transduction of multiple signals at different
stages mediated by both the preTCR and the TCR (1, 11).
Since the reconstitution experiments in Jurkat cells specifi-
cally address signal transduction through the mature TCR,
it is possible that other sequences in LAT may be necessary
for T cell development, particularly since the structure and
downstream signaling components of the preTCR may not
be identical to those of the mature TCR. In this study, we
asked whether the same four tyrosines required for T cell
activation in Jurkat cells are also required for T cell devel-
opment. To this end, we replaced the wild-type LAT gene
in mice with a LAT gene mutated in the four distal ty-
rosines by homologous recombination. Significantly, the
phenotype of knock-in mice that express the mutated
LAT protein was identical to that of LAT
 
 
 
/
 
 
 
 (null) mice;
thymocyte development was arrested at the immature
CD4
 
 
 
CD8
 
 
 
 stage and no mature T cells were present.
Knock-in mice that express wild-type LAT protein, gener-
ated by a similar strategy, displayed a normal T cell devel-
opmental profile. These results demonstrate that the distal
four tyrosine residues of LAT are essential for preTCR sig-
naling and T cell development in vivo.
 
Materials and Methods
 
Generation of LAT Knock-In Mice.
 
The LAT knock-in target-
ing construct depicted in Fig. 1 B contained the following DNA
elements: a 5
 
 
 
 mouse LAT genomic flank (from an original BglII
site to the EcoRI site in exon 5), LAT cDNA containing exons
5–12, the PGK-neomycin phosphotransferase gene flanked by
 
loxP
 
 sites (from pGKneoLoxP, Washington University Embry-
onic Stem Cell Core, St. Louis, MO), a 1.8-kb 3
 
 
 
 mouse ge-
nomic LAT flank (BamHI to EcoRV), and PGK-thymidine ki-
nase. Site-directed mutagenesis was performed on LAT cDNA
containing exons 5–12 (Quik-Change Site-Directed Mutagenesis
kit; Stratagene). Mutations were confirmed by DNA sequencing.
The targeting construct was linearized and transfected into 129
R1 ES cells by electroporation. DNA from G418 and gancyclovir
double-resistant clones was analyzed for homologous recombina-
tion by PCR. A three-primer PCR was used for screening ES
cell clones including a 5
 
  
 
primer from LAT intron 8 (5
 
 
 
-
GCTAATAACTGTACTGCAATGGC-3
 
 
 
), a 5
 
 
 
 primer from
the NEO gene (5
 
 
 
-GCATCGCCTTCTATCGCCTTC-3
 
 
 
), and
a 3
 
 
 
 primer from LAT genomic DNA that is downstream from
 
the 3
 
 
 
 targeting flank (5
 
 
 
-ATCACCTGCTGCTGGCAGTTC-
3
 
 
 
). Positive clones were confirmed for homologous recombina-
tion by Southern blot analysis (3
 
 
 
 end) and PCR (3
 
 
 
 and 5
 
 
 
 ends).
Positive clones were injected into C57BL/6 blastocysts using
standard procedures (10). Chimeric mice were mated to EIIa
CRE transgenic mice (12) that had been backcrossed onto a
C57BL/6 background for 10 generations. Progeny containing re-
combinant LAT alleles in which the PGK-NEO cassette had
been deleted by CRE-mediated recombination were intercrossed
to obtain homozygous mutant mice.
 
Cell Preparation and Flow Cytometry.
 
Single cell suspensions were
prepared from thymi and lymph nodes. Flow cytometry was per-
formed using a FACScan™ and CELLQuest™ software (Becton
Dickinson). Antibodies to mouse antigens were purchased from
BD PharMingen. LAT intracellular staining was performed essen-
tially as described previously (13) with the exception that deter-
gent permeabilization was for 4 min in 0.1% Triton X-100.
 
Anti-CD3 Injection.
 
Mice of
 
  
 
6 wk of age were injected in-
traperitoneally with 100 
 
 
 
g of purified anti-CD3 (monoclonal
antibody 145-2C11 in PBS). 1 wk later the mice were killed and
thymocytes were analyzed by flow cytometry.
 
Western Blot Analysis.
 
Thymocytes were lysed in Brij97 lysis
buffer (1% Brij97, 25 mM Tris-HCl, 150 mM NaCl, 5 mM
EDTA, and 1
 
  
 
complete protease inhibitor; Roche). Cleared ly-
sates were analyzed by gel electrophoresis and Western blot anal-
ysis was used with rabbit anti-LAT serum (3) or goat antiactin se-
rum (Santa Cruz Biotechnology, Inc.).
 
Results and Discussion
 
Generation of LAT Knock-In Mice.
 
Out of nine potential
tyrosine phosphorylation sites in human LAT, the distal
four tyrosine residues have been shown to bind signaling
molecules critical for T cell activation in Jurkat T cells (5).
Y136, Y175, Y195, and Y235 are the mouse counterparts
of those tyrosines and are shown in Fig. 1 A with the pro-
teins that bind the analogous sites in stimulated Jurkat T
cells. To determine the importance of these tyrosine resi-
dues for T cell development in mice, we wanted to substi-
tute a mutant form of LAT for wild-type LAT while still
maintaining the normal level and timing of LAT expres-
sion. Consequently, we used a “knock-in” gene targeting
approach, whereby the mouse wild-type LAT gene was re-
placed by a coding sequence containing tyrosine to phe-
nylalanine mutations of Y136, Y175, Y195, and Y235. The
targeting construct carrying the mutant LAT gene is shown
in Fig. 1 B. The endogenous LAT gene was replaced with
a minigene composed of genomic DNA containing exons
1–5 (up to and including an EcoRI site) and LAT cDNA
encoding exons 5–12 (from the EcoRI site). Use of the
minigene allowed for easier site-specific mutation of the
four LAT tyrosine residues, which are encoded in exons 7,
9, 10, and 11. In addition, the PGK-NEO gene was
flanked by 
 
loxP
 
 sites, which enabled its subsequent excision
in the mouse germline by crossing to EIIa-CRE recombi-
nase transgenic mice (14). This knock-in strategy should
result in expression of a mutant LAT protein at normal lev-
els with normal timing during ontogeny since the minigene
is placed in the proper genomic context by homologous re- 
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combination. However, since the minigene does not con-
tain all of the genomic elements of the wild-type gene
(e.g., the large eighth intron is deleted), we thought it im-
portant to generate in parallel a construct analogous to the
one carrying the four Y
 
→
 
F mutations but encoding ty-
rosines at positions 136, 175, 195, and 235 (i.e., wild-type
LAT).
Mice homozygous for the wild-type and mutant (LAT
protein with distal four tyrosines mutated to phenylalanines
[4YF]) LAT knock-in alleles were generated from two in-
dependent targeted ES cell clones each. The duplicate lines
exhibited identical phenotypes, indicating that it is unlikely
that genetic alterations in addition to the homologous re-
combination event at the LAT locus contributed to the
phenotypes observed (data not shown).The presence of
knock-in alleles and the excision of PGK-NEO were de-
tected by PCR of tail DNA, and LAT coding sequences
were confirmed by reverse transcription PCR of thy-
mocyte mRNA (data not shown). We designated homozy-
gous LAT wild-type knock-in mice with PGK-NEO excised
as LAT
 
WT/WT
 
 and homozygous LAT mutant knock-in mice
with PGK-NEO excised as LAT
 
4YF/4YF
 
. Mice containing
the wild-type LAT genomic sequences were designated
LAT
 
 
 
/
 
 
 
, and mice homozygous for the LAT null muta-
tion (described previously; reference 10) were designated
LAT
 
 
 
/
 
 
 
.
 
Characterization of LAT
 
WT/WT
 
 Mice.
 
LAT
 
WT/WT
 
 mice were
analyzed first to determine if LAT expressed from the re-
combinant, knock-in gene could support T cell develop-
ment. Analysis of LAT protein levels in total thymocytes by
intracellular staining (Fig. 2 A) and by Western blot analysis
(Fig. 2 B) revealed that LAT
 
WT/WT
 
 mice contained LAT
protein at levels that were slightly lower than those in
LAT
 
 
 
/
 
 
 
 mice but higher than those in LAT
 
 
 
/
 
 
 
 (heterozy-
gous) mice. Significantly, the LAT protein levels in LAT
 
 
 
/
 
 
 
mice are sufficient to completely support thymocyte devel-
opment (10).
Total thymocyte numbers were normal in LAT
 
WT/WT
 
mice (Fig. 3, and data not shown), and the percentages of
CD4
 
 
 
CD8
 
 
 
, CD4
 
 
 
CD8
 
 
 
, and mature CD4
 
 
 
 and CD8
 
 
 
thymocytes were comparable in LAT
 
WT/WT
 
 and LAT
 
 
 
/
 
 
 
mice (Fig. 3). In addition, surface levels of activation/dif-
ferentiation markers including CD3
 
 
 
, CD5, CD69, CD24,
and CD25 were essentially the same on thymocytes from
LAT
 
WT/WT
 
 and LAT
 
 
 
/
 
 
 
 mice (Fig. 3, and data not shown).
Likewise, the number of peripheral CD4 and CD8 T cells
were normal in LAT
 
WT/WT
 
 mice and these cells expressed
similar levels of CD3
 
 
 
, CD5, CD44, and CD62L to the
corresponding cells from LAT
 
 
 
/
 
 
 
 mice (Fig. 3, and data
not shown). B and NK cell numbers were also were nor-
mal in LAT
 
WT/WT
 
 mice (data not shown). Collectively,
these results indicated that the knock-in strategy could be
Figure 1. (A) Schematic representation of the mouse LAT molecule. Domains include EC (extracellular), TM (transmembrane), and CY (cytoplas-
mic). C denotes cysteine residues that are sites of palmitoylation and Y denotes tyrosine residues that are potential phosphorylation sites. Mutation of
Y132 (human counterpart of Y136 in mouse LAT) results in a loss of binding of PLC- 1 in Jurkat T cells and mutation of Y171, Y191, and Y226 (hu-
man counterparts of Y175, Y195, and Y235 in mouse) results in a loss of Gads and Grb-2 binding (5). (B) Strategy for 4YF LAT knock-in mutation. The
knock-in targeting construct contains a LAT minigene (LAT genomic DNA 5  to the EcoRI site in exon 5 and LAT cDNA 3  to the EcoRI site), the
PGK-NEO gene flanked by loxP sites, and the PGK-TK gene (not shown). The LAT4YF-FLOX gene is generated by homologous recombination of
the knock-in targeting construct and the wild-type mouse LAT gene. After exposure to CRE recombinase, the LAT4YF allele (bottom) is produced.
The LATWT allele was made in an analogous fashion but does not contain the four Y→F mutations. 
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employed to analyze the effect of specific LAT tyrosines on
T cell development.
 
Characterization of LAT
 
4YF/4YF
 
 Mice.
 
LAT
 
4YF/4YF
 
 mice ex-
hibited a phenotype dramatically different from that of
LAT
 
WT/WT
 
 mice resembling that of LAT
 
 
 
/
 
 
 
 mice, al-
though LAT
 
4YF/4YF
 
 thymocytes contained similar LAT pro-
tein levels to LAT
 
 
 
/
 
  
 
and LAT
 
WT/WT
 
 mice (Fig. 2 A). We
also compared LAT protein levels from LAT
 
4YF/4YF
 
 thy-
mocytes to those from recombinase-activating gene (Rag)
1
 
 
 
/
 
 
 
 and CD3
 
 
 
 /  thymocytes by Western blot analysis,
since these mice all have thymi of similar size that contain
similar thymocyte subpopulations. Some experiment to ex-
periment variability was observed; however, the protein
levels in LAT4YF/4YF thymocytes were consistently between
0.5–1.0 times the level of LAT present in thymocytes from
Rag1 /  and CD3  /  mice (Fig. 2 B).
We reported previously that T cell, but not B cell, mast
cell, NK cell, or platelet development is blocked in LAT / 
mice (10). Therefore, we focused our analysis of LAT4YF/4YF
mice on T cell development. Thymi from LAT4YF/4YF
Figure 2. LAT protein expression in LAT knock-in thymocytes. (A) Intracel-
lular LAT staining of LAT knock-in thymocytes. Thymocytes were permeabi-
lized and stained with anti-LAT antiserum and PE-conjugated anti–rabbit IgG
and analyzed by flow cytometry. The gray (unfilled) line depicts normal rabbit
antiserum and PE-conjugated anti-rabbit IgG control staining. Numbers indicate
mean fluorescence intensity. (B) Western blot analysis of LAT knock-in thy-
mocytes. Total thymocyte detergent soluble lysates were analyzed by Western blot analysis using anti-LAT rabbit antiserum. The blot was stripped and
reprobed for actin. Values beneath the blot indicate the densitometric ratio of LAT protein to actin protein.
Figure 3. Flow cytometric analysis of
LATWT/WT thymocytes and lymph node
cells. Single cell suspensions from thymus
and lymph node were surface stained and
analyzed by flow cytometry. Two color
plots of CD4 and CD8 are shown as are one
color histograms for CD3  and CD5. Gray
lines indicate isotype-matched negative
control antibody staining. Thymocyte num-
bers are given in parentheses.139 Sommers et al.
mice were small, typically about one-tenth the size of
thymi from LAT /  mice (similar to the size of LAT / 
thymi; Fig. 4 A, and data not shown). Moreover, the aver-
age thymocyte size, as measured by forward and side scat-
ter, was larger in LAT4YF/4YF mice than in LAT /  or
LATWT/WT mice suggesting that these cells were immature
(Fig. 4 A). Consistent with this finding, all of the thy-
mocytes from LAT4YF/4YF mice were CD4 CD8 . CD3 
(Fig. 4 A) and TCR-  (data not shown) were nearly un-
detectable on the surface of LAT4YF/4YF thymocytes;
however, intracellular TCR-  staining was detected in
LAT4YF/4YF and LAT /  thymocytes indicating that the
Figure 4. Flow cytometric analysis of LAT4YF/4YF thy-
mocytes. (A) Single cell thymocyte suspensions were sur-
face stained and analyzed by flow cytometry. Dot plots
show forward scatter versus side scatter measurements and
CD4 versus CD8 staining. Histograms show CD3  and
CD5 staining. Gray lines indicate isotype-matched negative
control antibody staining. Total thymocyte numbers are
given in parentheses. (B) Thymocytes gated as negative for
CD4, CD8, CD3 , and B220 were analyzed for surface ex-
pression of CD44 and CD25. Thymocytes gated as nega-
tive for CD4, CD8, and B220 were analyzed for CD3 ,
TCR- , and TCR-   surface expression.140 LAT Knock-In Mice
TCR-  gene is rearranged and expressed (data not shown).
To determine more specifically where the block in T cell
development occurred in LAT4YF/4YF mice, thymocytes
were stained for CD25 and CD44. Immature CD4 CD8 
thymocytes progress through the four developmental
stages before differentiating to the CD4 CD8  stage:
CD25 CD44 →CD25 CD44 →CD25 CD44 →CD25 
CD44  (15). As shown in Fig. 4 B, T cell development
was blocked at the CD25 CD44  stage in LAT4YF/4YF
mice. Significantly, T cell development is also blocked at
this stage in LAT /  mice (10) and in Rag /  (16, 17),
CD3  /  (18, 19), and SLP76 /  mice (20), consistent
with the idea that preTCR signals are required for the de-
velopment of CD4 CD8 CD25 CD44  thymocytes to
the CD4 CD8 CD25 CD44  and subsequently, to the
CD4 CD8  stage.
Clonotype independent complexes (CICs), which con-
tain CD3 subunits paired with the chaperone calnexin, can
be expressed on the cell surface of CD4 CD8 CD25 
CD44  thymocytes (21). CICs have been most readily
demonstrated on the surface of cells that lack expression of
clonotypic subunits, such as from Rag /  mice. Signal
transduction through the preTCR or through CICs can
be triggered by injection of anti-CD3  which induces
proliferation of CD4 CD8  thymocytes and their mat-
uration to the CD4 CD8  stage (22). To determine if
LAT4YF/4YF thymocytes could transduce signals though the
preTCR or CICs, mice were injected with anti-CD3 . In
LAT /  mice, this treatment does not result in thy-
mocyte maturation or proliferation (Fig. 5, and reference
10), presumably because signal transduction downstream of
the preTCR or CICs is blocked. Injection of anti-CD3 
also did not result in thymocyte maturation or proliferation
in LAT4YF/4YF mice (Fig. 5), indicating that even under
these strong stimulation conditions the 4YF mutant LAT
protein is unable to function in preTCR or CIC signal
transduction.
Finally, all of the mature T cell subsets that were absent
in LAT /  mice were also absent in LAT4YF/4YF mice.
These include CD4 CD8  TCR-    thymocytes
(NK1.1  T cells; Fig. 4 B, and reference 23), thymic and
peripheral      TCR  T cells (Fig. 4 A, and data not
shown), peripheral    TCR CD4  and CD8  T cells,
and intestinal intraepithelial T lymphocytes (data not
shown).
These results confirm a critical role for LAT during T
cell development and extend our previous data obtained by
standard knockout technology to identify LAT tyrosine
residues essential for thymocyte maturation. In Jurkat cells,
mutation of Y132 (the human counterpart of Y136 in
mouse LAT) abrogates association of PLC- 1 with LAT
whereas mutation of Y171, Y191, and Y226 (the human
Figure 5. Defective preTCR signaling in LAT4YF/4YF
thymocytes. 6-wk-old Rag1 / , LAT / , or LAT4YF/4YF
mice received a single intraperitoneal injection of anti-
CD3  (145-2C11, lower panels) or PBS (control, upper
panels). 1 wk later, total thymocytes were analyzed by
flow cytometry. Two color plots of CD4 versus CD8
and CD44 versus CD25 (gated on CD4, CD8, CD3 ,
and B220-negative cells) are depicted. Thymocyte num-
bers are shown in parentheses.141 Sommers et al.
counterparts of Y175, Y195, and Y235) abrogates associa-
tion of Grb-2 and Gads with LAT. If these results from
Jurkat cells can be extrapolated to immature thymocytes,
then associations with PLC- 1, Grb-2, and Gads (and
other proteins) could be critical for LAT function in
preTCR signaling. By analogy to TCR signaling in mature
T cells, several downstream pathways are likely to be af-
fected by the loss of these associations, in particular, path-
ways dependent on calcium mobilization and Ras-MAPK
activation. Gads may also activate downstream signaling
pathways via its association with SLP-76 (for a review, see
reference 24). SLP-76 also associates with Vav and may
therefore regulate activation of Rac/cdc42 and actin reor-
ganization (for a review, see reference 25). Interestingly,
the phenotype of SLP-76 /  mice with respect to T cell
development is similar to that of LAT /  and LAT4YF/4YF
mice (20). Given the importance of these interactions for
signal transduction, it might be predicted that 4YF LAT
would act as an inert or null protein. Consistent with this
notion, LAT /4YF mice display normal thymus size and
normal T cell development indicating that the 4YF LAT
protein does not exert a dominant negative effect in the
presence of the wild-type protein.
In addition to the necessity of the four distal tyrosines for
T cell development, recent experiments suggest that they
are also sufficient for T cell development (unpublished
data). A retrovirus expressing a mutant LAT protein con-
taining only the four distal tyrosines (i.e., having the first
five tyrosines mutated to phenylalanines) was used to infect
LAT /  bone marrow cells and these cells were adoptively
transferred to irradiated LAT /  mice. This mutant form of
LAT was fully capable of restoring T cell development
when introduced into LAT /  mice, indicating that of the
nine potential tyrosine phosphorylation sites in LAT, the
distal four were sufficient for T cell development.
We had previously shown that LAT /  mice exhibit
normal T cell development suggesting that thymocyte mat-
uration and T cell function are not sensitive to modest al-
terations in LAT expression. Consistent with this idea,
LAT protein levels in LATWT/WT thymocytes were slightly
lower than in wild-type levels but thymocyte development
was unaffected. It remains to be determined if T cell devel-
opment is altered by overexpression of LAT. Mast cell and
platelet activation are also affected in LAT /  mice (26,
27). Although not specifically addressed in this study, the
availability of the knock-in mice will allow us to test the
ability of the 4YF mutant protein to function in these lin-
eages.
Importantly, the observation that LATWT/WT mice ex-
hibit normal T cell development validates the knock-in
strategy for the study of LAT function in T cell develop-
ment. These results imply that it should be possible to gen-
erate additional LAT knock-in mice that contain single or
multiple Y→F mutations in LAT using a similar approach.
These studies should enable the systematic assessment of
the contribution of specific LAT tyrosines and LAT-cou-
pled signal transduction pathways to T cell development.
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